KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments: 2015-2018

Historic Preferred Dividend Payments for Teva Pharmaceutical Industries (TEVA) over the last 4 years, with Dec 2018 value amounting to $249.0 million.

  • Teva Pharmaceutical Industries' Preferred Dividend Payments fell 16.92% to $54.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $249.0 million, marking a year-over-year decrease of 4.23%. This contributed to the annual value of $249.0 million for FY2018, which is 4.23% down from last year.
  • Teva Pharmaceutical Industries' Preferred Dividend Payments amounted to $249.0 million in FY2018, which was down 4.23% from $260.0 million recorded in FY2017.
  • Teva Pharmaceutical Industries' 5-year Preferred Dividend Payments high stood at $261.0 million for FY2016, and its period low was $15.0 million during FY2015.
  • For the 3-year period, Teva Pharmaceutical Industries' Preferred Dividend Payments averaged around $256.7 million, with its median value being $260.0 million (2017).
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Preferred Dividend Payments skyrocketed by 1,640.00% in 2016 and then declined by 4.23% in 2018.
  • Over the past 4 years, Teva Pharmaceutical Industries' Preferred Dividend Payments (Yearly) stood at $15.0 million in 2015, then spiked by 1,640.00% to $261.0 million in 2016, then fell by 0.38% to $260.0 million in 2017, then fell by 4.23% to $249.0 million in 2018.